KC and non-KC patients tear fluid treatment did not cause any significant changes in the apical pro-MMP9 or 2 gelatinase activity or PLA2G2A levels (p = 0.967) between control and KC tear fluid treatment (Figures 2G and 2H). This evidence concerns the gene MMP9 and keratoconus.